Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

RVAC Completes B Round for mRNA Drugs, Bringing Total Raised to $140 Million

publication date: Apr 27, 2022

RVAC Medicines, a Singapore mRNA platform company, completed a Series B funding led by CBC Group that brings total funds raised since its inception to $140 million. CBC also incubated the company. RVAC is headquartered in Singapore with R&D centers in Boston and Shanghai. The company will target unmet medical needs, especially in emerging markets, by developing novel vaccines and therapeutics including a potentially best-in-class COVID vaccine. It will use the proceeds to develop its pipeline and to build a new R&D center in Singapore and manufacturing facilities in Singapore and China

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here